Ushijima, Futoshi
Hase, Tetsunari http://orcid.org/0000-0002-9653-8424
Yamashita, Yuki
Kim, Hangsoo
Shimokata, Tomoya
Kondo, Chiaki
Sato, Tomonori
Baba, Tomoya
Watanabe, Shohei
Futamura, Keisuke
Ando, Yuichi
Mizuno, Masashi
Ishii, Makoto
Article History
Received: 8 July 2023
Accepted: 30 October 2023
First Online: 21 December 2023
Declarations
:
: T.H. received personal fees and research funding from AstraZeneca KK outside the submitted work. Y.A. received personal fees from Chugai Pharmaceutical Co., Ltd. and Bayer Holding Ltd., and research funding from Chugai Pharmaceutical Co., Ltd., Bayer Holding Ltd., BeiGene Inc., and Geo Holdings Co., Ltd. M.I. received personal fees from AstraZeneca KK outside the submitted work. All remaining authors have no conflicts of interest to declare.
: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Given that this is a case report without the inclusion of any identifying information, formal consent was not required.